======= IARS ======= == Gene Information == * **Official Symbol**: IARS1 * **Official Name**: isoleucyl-tRNA synthetase 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=3376|3376]] * **UniProt**: [[https://www.uniprot.org/uniprot/P41252|P41252]] * **Interactions**: [[https://thebiogrid.org/search.php?search=IARS&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20IARS|Open PubMed]] * **OMIM**: [[https://omim.org/entry/600709|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Catalyzes the specific attachment of an amino acid to its cognate tRNA in a 2 step reaction: the amino acid (AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA. {ECO:0000269|PubMed:8052601}. |Anticodon 1| |tRNA-synt 1| |tRNA-synt 1g| |isoleucine-tRNA ligase activity| |isoleucyl-tRNA aminoacylation| |aminoacyl-tRNA synthetase multienzyme complex| |aminoacyl-tRNA editing activity| |aminoacyl-tRNA metabolism involved in translational fidelity| |regulation of translational fidelity| |GTPase binding| |tRNA aminoacylation for protein translation| |tRNA aminoacylation| |amino acid activation| |tRNA binding| |osteoblast differentiation| |tRNA metabolic process| |ossification| |cellular amino acid metabolic process| |translation| |peptide biosynthetic process| |ncRNA metabolic process| |amide biosynthetic process| |peptide metabolic process| |cellular amide metabolic process| |carboxylic acid metabolic process| |oxoacid metabolic process| |organic acid metabolic process| |organonitrogen compound biosynthetic process| |ATP binding| |cellular nitrogen compound biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |small molecule metabolic process| |macromolecule biosynthetic process| |membrane| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp514|Phorbol-12-myristate-13-acetate 0.57μM R08 exp514]]|-1.76| |[[:results:exp65|Mubritinib 0.2μM R02 exp65]]|-1.7| |[[:results:exp165|RO-3306 3 to 4μM on day4 R04 exp165]]|1.73| |[[:results:exp272|CHIR-124 0.04μM R06 exp272]]|1.75| |[[:results:exp28|Pimelic-diphenylamide-106 5μM R00 exp28]]|1.79| |[[:results:exp19|Etoposide 1μM R00 exp19]]|1.97| |[[:results:exp85|UM0129480 7μM R02 exp85]]|2.05| |[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|2.54| |[[:results:exp2|5-Fluorouracil 20μM R00 exp2]]|2.6| ^Gene^Correlation^ |[[:human genes:h:hars|HARS]]|0.598| |[[:human genes:m:mars|MARS]]|0.448| |[[:human genes:m:meaf6|MEAF6]]|0.425| Global Fraction of Cell Lines Where Essential: 709/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|27/28| |blood|28/28| |bone|26/26| |breast|30/33| |central nervous system|55/56| |cervix|4/4| |colorectal|16/17| |esophagus|11/13| |fibroblast|1/1| |gastric|16/16| |kidney|19/21| |liver|20/20| |lung|73/75| |lymphocyte|15/16| |ovary|26/26| |pancreas|24/24| |peripheral nervous system|15/16| |plasma cell|14/15| |prostate|1/1| |skin|24/24| |soft tissue|9/9| |thyroid|2/2| |upper aerodigestive|19/22| |urinary tract|29/29| |uterus|5/5| == Essentiality in NALM6 == * **Essentiality Rank**: 247 * **Expression level (log2 read counts)**: 9.14 {{:chemogenomics:nalm6 dist.png?nolink |}}